B. Desoize

Most-cited papers

1. Multicellular resistance: a paradigm for clinical resistance?

   B. Desoize, J. Jardillier

   2000Critical reviews in oncology/hematology422 citations

   Semantic Scholar

   Save

2. Particular aspects of platinum compounds used at present in cancer treatment.

   B. Desoize, C. Madoulet

   2002Critical reviews in oncology/hematology396 citations

   Semantic Scholar

   Save

3. Metals and metal compounds in cancer treatment.

   B. Desoize

   2004Anticancer Research268 citations

   Semantic Scholar

   Save

4. Gallium in cancer treatment.

   P. Collery, B. Keppler, C. Madoulet, B. Desoize

   2002Critical reviews in oncology/hematology262 citations

   Semantic Scholar

   Save

5. Cell culture as spheroids: an approach to multicellular resistance.

   B. Desoize, D. Gimonet, J. C. Jardiller

   1998Anticancer Research94 citations

   Semantic Scholar

   Save

6. Effects of cannabinoids on macromolecular synthesis and replication of cultured lymphocytes.

   G. Nahas, A. Morishima, B. Desoize

   1977Federation proceedings93 citations

   Semantic Scholar

   Save

7. Anticancer drug resistance and inhibition of apoptosis.

   B. Desoize

   1994Anticancer Research61 citations

   Semantic Scholar

   Save

8. Metals and metal compounds in carcinogenesis.

   B. Desoize

   2003In Vivo51 citations

   Semantic Scholar

   Save

9. Individual dose adaptation of anticancer drugs.

   B. Desoize, J. Robert

   1994European Journal of Cancer48 citations

   Semantic Scholar

   Save

10. Effects of Psychotropic Drugs on DNA Synthesis in Cultured Lymphocytes

    G. Nahas, B. Desoize, Colette Léger

    1979Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine37 citations

    Semantic Scholar

    Save

11. Cancer and Metals and Metal Compounds

    B. Desoize

    200235 citations

    Semantic Scholar

    Save

12. Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours.

    B. Desoize, F. Marechal, A. Cattan

    1990British Journal of Cancer26 citations Open access

    Semantic Scholar

    Save

13. Comparison of Phosphatase Isoenzymes PAP and PSA with Bone Scan in Patients with Prostate Carcinoma

    S. Amico, J. Liehn, B. Desoize, Hélène Larbre +2 more

    1991Clinical Nuclear Medicine24 citations

    Semantic Scholar

    Save

14. Cancer and metals and metal compounds: part II--cancer treatment.

    B. Desoize

    2002Critical reviews in oncology/hematology23 citations

    Semantic Scholar

    Save

15. Cancer and metals and metal compounds: part I--carcinogenesis.

    B. Desoize

    2002Critical reviews in oncology/hematology23 citations

    Semantic Scholar

    Save

16. Correlation of clinical pharmacokinetic parameters of cisplatin with efficacy and toxicity.

    B. Desoize, F. Marechal, H. Millart, A. Cattan

    1991Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie22 citations

    Semantic Scholar

    Save

17. In‐vitro cytotoxic activity of cross‐linked protein microcapsules

    B. Desoize, J. Jardillier, K. Kanoun, D. Guérin +1 more

    1986The Journal of pharmacy and pharmacology22 citations

    Semantic Scholar

    Save

18. Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration.

    B. Desoize, G. Berthiot, L. Manot, P. Coninx +1 more

    1996European Journal of Cancer20 citations

    Semantic Scholar

    Save

19. Inhibitory Effects of Δ9-Tetrahydrocannabinol on Nucleic Acid Synthesis and Proteins in Cultured Lymphocytes

    G. Nahas, B. Desoize, J. Hsu, A. Morishima

    197620 citations

    Semantic Scholar

    Save

20. Combination chemotherapy with cisplatin, etoposide and gallium chloride for lung cancer: individual adaptation of doses.

    P. Collery, M. Morel, B. Desoize, H. Millart +6 more

    1991Anticancer Research16 citations

    Semantic Scholar

    Save

21. Chronology of combined chemotherapy (5FU) and radiotherapy. I. In vitro study.

    Y. Carpentier, L. Demange, M. Loirette, J. Hivet +1 more

    1993Anticancer Research15 citations

    Semantic Scholar

    Save

22. The effect of 12-alkoxy modification on the in vitro antileukaemic activity of N-methyl 2,3,8,9-tetramethoxybenzo[c]phenanthridinium salts.

    S. Mackay, L. Comoe, B. Desoize, O. Duval +2 more

    1998Anti-Cancer Drug Design13 citations

    Semantic Scholar

    Save

23. "Antibodies in cancer treatment".

    B. Desoize

    2007Critical reviews in oncology/hematology10 citations

    Semantic Scholar

    Save

24. [Apoptosis or programmed cell death: concepts, mechanisms and contribution in oncology].

    B. Desoize, S. Sen

    1992Bulletin du Cancer10 citations

    Semantic Scholar

    Save

25. Comparison of two dose prediction models for cisplatin.

    B. Desoize, P. Dumont, L. Manot, S. Urien +2 more

    1994Anticancer Research9 citations

    Semantic Scholar

    Save

26. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.

    B. Desoize, V. Veiler, C. Pourny, L. Comoe +1 more

    1989Anticancer Research9 citations

    Semantic Scholar

    Save

27. Plasma acid and alkaline phosphatase in patients with breast cancer.

    M. Nguyen, J. Bonneterre, B. Hecquet, B. Desoize +1 more

    1991Anticancer Research7 citations

    Semantic Scholar

    Save

28. Immunosuppressive agents are also carcinogens.

    B. Desoize

    2005Critical reviews in oncology/hematology6 citations

    Semantic Scholar

    Save

29. Puzzles in the clinical pharmacokinetics of fluorouracil.

    B. Desoize, O. Bouché, G. Berthiot, P. Coninx

    1998Anticancer Research6 citations

    Semantic Scholar

    Save

30. Superiority of perfusion over bolus administration in cancer chemotherapy: proposition of a compartmental model.

    B. Desoize, E. R. Garrett

    1989Medical Hypotheses6 citations

    Semantic Scholar

    Save

31. Antibodies in cancer treatment-II.

    B. Desoize

    2007Critical reviews in oncology/hematology5 citations

    Semantic Scholar

    Save

32. Stromal reaction and tumour growth.

    B. Desoize

    2004Critical reviews in oncology/hematology5 citations

    Semantic Scholar

    Save

33. Evaluation of two dose individualisation methods for carboplatin.

    B. Desoize, R. Dufour, S. Urien, M. Kaltenbach +1 more

    1996Anticancer Research5 citations

    Semantic Scholar

    Save

34. Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975).

    B. Desoize, Y. Carpentier, D. Guerrier

    1989Anticancer Research5 citations

    Semantic Scholar

    Save

35. [To which criterion should the dosage of anticancer drug be adapted?].

    B. Desoize

    1993Bulletin du Cancer4 citations

    Semantic Scholar

    Save

36. [Cytotoxic effects of root extracts of Fagara zanthoxyloides Lam. (Rutaceae) on the human erythroleukemia K 562 cell line].

    L. Comoë, J. Kouamouo, P. Jeannesson, B. Desoize +3 more

    1987Annales Pharmaceutiques Françaises4 citations

    Semantic Scholar

    Save

37. Alkaline phosphatase isoenzyme reactivity with wheat-germ agglutinin.

    B. Desoize, L. Cravero, J. Jardillier

    1986Clinical Chemistry4 citations

    Semantic Scholar

    Save

38. Inhibition by THC of thymidine transport: a plasma membrane effect.

    B. Desoize, Colette Léger, J. Jardillier, G. Nahas

    1978Advances in the biosciences4 citations

    Semantic Scholar

    Save

39. Imaging and cancer--I.

    B. Desoize

    2008Critical reviews in oncology/hematology3 citations

    Semantic Scholar

    Save

40. [Multicellular resistance: another mechanisms of pleiotropic resistance?].

    B. Desoize, D. Gimonet, J. Jardillier

    1998Bulletin du Cancer2 citations

    Semantic Scholar

    Save

41. Reversion of resistance to adriamycin by vanadate on 4 friend-cell sublines.

    B. Desoize, F. Briois, Y. Carpentier

    1994International Journal of Oncology2 citations

    Semantic Scholar

    Save

42. Chronology of combined chemotherapy (5FU) and radiotherapy. II. In vivo study.

    L. Demange, Y. Carpentier, M. Loirette, J. Hivet +2 more

    1993Anticancer Research2 citations

    Semantic Scholar

    Save

43. Growth inhibition and morphological alteration of L 1210 cells by polyglutaraldehyde nanospheres.

    H. Bobichon, B. Desoize, I. Chami, P. Bouchet +1 more

    1987Journal of submicroscopic cytology2 citations

    Semantic Scholar

    Save

44. [Effect of methotrexate on oxygen consumption of L1210 cells and their isolated mitochondria].

    J. Kouamouo, C. Trentesaux, B. Desoize, Y. Carpentier +1 more

    1981Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie2 citations

    Semantic Scholar

    Save

45. [In vivo evaluation of potential doubling time (Tpot) of tumors by flow cytometry: practical difficulties and possible solutions].

    M. Gorisse, B. Desoize, Y. Carpentier, T. Nguyen

    1996Bulletin du Cancer1 citations

    Semantic Scholar

    Save

46. [Apoptosis and programmed cell death].

    B. Desoize

    1995Bulletin du Cancer1 citations

    Semantic Scholar

    Save

47. Limited Sampling and Dose Prediction Model for Cisplatin Using a Bayesian Approach

    B. Desoize, R. Dufour, S. Urien

    19941 citations

    Semantic Scholar

    Save

48. [Correlations between clinical pharmacodynamics and pharmacokinetics of cisplatin and etoposide].

    B. Desoize, F. Marechal, A. Cattan

    1993Annales de Biologie Clinique1 citations

    Semantic Scholar

    Save

49. [Effect of methotrexate on glycolysis of leukemia L 1210 cells cultivated in vitro].

    Y. Carpentier, B. Desoize, C. Rollet, J. Jardillier

    1978Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles1 citations

    Semantic Scholar

    Save

50. Imaging and cancer - part III.

    B. Desoize

    2009Critical reviews in oncology/hematology0 citations

    Semantic Scholar

    Save